Hmgcl-KO Mouse
Common Name
Hmgcl-KO
제품 ID
S-KO-17323
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-15356-Hmgcl-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Hmgcl-KO Mouse (카탈로그 번호 S-KO-17323)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Hmgcl-KO
품종 계통계통 ID
KOCMP-15356-Hmgcl-B6J-VA
유전자명
제품 ID
S-KO-17323
유전자 별칭
HL
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 4
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000030432
NCBI 전사체 ID
NM_008254
타겟 영역
Exon 5
유효 영역 크기
~0.1 kb
유전자 연구 개요
Hmgcl, also known as 3-hydroxy-3-methylglutaryl-CoA lyase, is a key enzyme. It catalyzes the cleavage of HMG-CoA into acetyl-CoA and acetoacetic acid, serving as a rate-limiting enzyme in ketone body metabolism and being involved in leucine degradation [1,2,3]. It is associated with multiple biological pathways related to energy metabolism and epigenetic regulation. Genetic models are valuable for studying its functions.
In hepatocellular carcinoma (HCC), Hmgcl depletion promoted proliferation and metastasis, while overexpression reversed this trend. Hmgcl-induced β-hydroxybutyrate production increased histone H3K9 acetylation, promoting DPP4 transcription, leading to HCC cells' vulnerability to ferroptosis [1]. In glioblastoma, knockdown of Hmgcl suppressed proliferation and invasion, as Hmgcl-mediated changes in acetyl-CoA levels altered H3K27ac modification, activating the FOXM1/β-catenin pathway [2]. In osteosarcoma, Hmgcl is downregulated, and its overexpression inhibits cell proliferation, migration, and invasion, as well as tumor growth in vivo, by inhibiting the PI3K/AKT/mTOR signaling pathway via β-HB [3]. In lung cancer, Hmgcl is downregulated, and TNFα-mediated phosphorylation by IKKβ promotes its degradation via NEDD4, with overexpression of Hmgcl inhibiting tumorigenicity [4]. In pancreatic cancer, depletion of Hmgcl impedes migration, invasiveness, and tumor growth, while β-OHB (produced by Hmgcl) stimulates metastatic dissemination [5]. In nasopharyngeal carcinoma, inactivation of Hmgcl promotes proliferation and metastasis by suppressing oxidative stress [6]. In benign prostatic hyperplasia, miR-1202 targets Hmgcl to regulate cell proliferation, apoptosis, and epithelial-to-mesenchymal transition [7].
In conclusion, Hmgcl plays crucial roles in energy metabolism-related biological processes. Through gene knockout or conditional knockout mouse models and other functional studies, its functions in various cancers and benign prostatic hyperplasia have been revealed. Understanding Hmgcl's functions provides potential therapeutic targets for these diseases.
References:
1. Cui, Xiaohan, Yun, Xiao, Sun, Meiling, Qin, Xihu, Yu, Wenbin. 2022. HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility. In Hepatology international, 17, 377-392. doi:10.1007/s12072-022-10459-9. https://pubmed.ncbi.nlm.nih.gov/36508088/
2. Sun, Yanfei, Mu, Guangjing, Zhang, Xuehai, Han, Mingzhi, Huang, Bin. . Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma. In Neuro-oncology, 26, 653-669. doi:10.1093/neuonc/noad232. https://pubmed.ncbi.nlm.nih.gov/38069906/
3. Liu, Wenda, Xia, Kezhou, Huang, Xinghan, Xiong, Chen, Guo, Weichun. 2025. HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway. In Journal of translational medicine, 23, 219. doi:10.1186/s12967-025-06227-6. https://pubmed.ncbi.nlm.nih.gov/39985081/
4. Zhong, Chenxi, Xiong, Guosheng, Yang, Haitang, Fang, Wentao, Deng, Yuezhen. 2023. Phosphorylation by IKKβ Promotes the Degradation of HMGCL via NEDD4 in Lung Cancer. In International journal of biological sciences, 19, 1110-1122. doi:10.7150/ijbs.82015. https://pubmed.ncbi.nlm.nih.gov/36923932/
5. Gouirand, Victoire, Gicquel, Tristan, Lien, Evan C, Vander Heiden, Matthew G, Vasseur, Sophie. 2022. Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. In The EMBO journal, 41, e110466. doi:10.15252/embj.2021110466. https://pubmed.ncbi.nlm.nih.gov/35307861/
6. Luo, Wenqi, Qin, Liting, Li, Bo, Zhou, Xiaoying, Li, Ping. 2017. Inactivation of HMGCL promotes proliferation and metastasis of nasopharyngeal carcinoma by suppressing oxidative stress. In Scientific reports, 7, 11954. doi:10.1038/s41598-017-11025-2. https://pubmed.ncbi.nlm.nih.gov/28931870/
7. Wang, Zhenting, Yin, Xianlai, Yang, Peng, Gong, Binghao, Liu, Haifang. . miR-1202 regulates BPH-1 cell proliferation, apoptosis, and epithelial-to-mesenchymal transition through targeting HMGCL. In Acta biochimica et biophysica Sinica, 56, 675-687. doi:10.3724/abbs.2024001. https://pubmed.ncbi.nlm.nih.gov/38551020/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
